This is in part corroborated by reports that the upregulation of MED28 expression by FOXD3-AS1, with concomitant suppression of miR-127-3p, promoted non-small cell lung cancer (NSCLC) cell proliferation and invasion, in vitro, and enhanced xenograft tumor growth (30). Here, FOXD3 is linked to non-small cell lung carcinoma.